logo
Book a meeting
CV Therapeutics

Cv Therapeutics

Biotechnology, 3172 Porter Dr, Palo Alto, California, 94304, United States, 201-500 Employees

cvt.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +15*********

Who is CV THERAPEUTICS

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular di...

Read More

lock icon Get Full Access
map
  • 3172 Porter Dr, Palo Alto, California, 94304, United States Headquarters: 3172 Porter Dr, Palo Alto, California, 94304, United States
  • 1991 Date Founded: 1991
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies
  • Chris John CEO:   Chris John

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CV THERAPEUTICS

email-formate-icon
View Email Formats for CV Therapeutics
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding CV Therapeutics

Answer: CV Therapeutics's headquarters are located at 3172 Porter Dr, Palo Alto, California, 94304, United States

Answer: CV Therapeutics's phone number is +15*********

Answer: CV Therapeutics's official website is https://cvt.com

Answer: CV Therapeutics's revenue is $100 Million to $250 Million

Answer: CV Therapeutics's SIC: 2834

Answer: CV Therapeutics's NAICS: 325412

Answer: CV Therapeutics has 201-500 employees

Answer: CV Therapeutics is in Biotechnology

Answer: CV Therapeutics contact info: Phone number: +15********* Website: https://cvt.com

Answer: CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access